Bauke de Boer

Bauke de Boer serves as an Assistant Professor at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen. He conducts research as part of the Porse Group led by Professor Bo Torben Porse, focusing on molecular mechanisms in acute myeloid leukemia (AML) from his office at Ole Maaløes Vej 5, Copenhagen.

His research program centers on:

• Epigenetic regulation in leukemogenesis through histone modifications
• Inflammatory signaling pathways in leukemic microenvironments
• Development of single-cell proteomic methodologies for cancer research
• Molecular interactions between tumor suppressors and immature gene programs

Analysis of his publication trajectory (2020-2025) reveals an evolving focus from inflammatory niche characterization (IL1-IL1RAP axis) to epigenetic control mechanisms (KDM5C tumor suppression) and cutting-edge proteomic technology development. This progression demonstrates an integrative approach combining molecular biology, epigenetics, and advanced instrumentation to identify therapeutic vulnerabilities in AML.

No scientific awards were documented in the provided materials. Information regarding student supervision or research grants was not specified in the available texts. Dr. de Boer operates within the collaborative framework of the Porse Group at BRIC, which provides access to state-of-the-art genomics and proteomics facilities and maintains extensive national and international research networks as evidenced by multi-institutional publications.